Skip to main content
SpringerLink
Log in

Beeinflussung der Pathogenität von Clostridium difficile durch Saccharomyces boulardii

  • Conference paper
Ökosystem Darm V

  • 57 Accesses

Zusammenfassung

Das Ökosystem Darm beinhaltet alle Mikroorganismen und die dort vorhandenen abiotischen und biotischen Standortfaktoren. Zur Umwelt Darm gehören allgemeine und spezielle Milieufaktoren, Abwehrmechanismen und Siedlungsfaktoren, die das Ökosystem regulieren [15].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bernhardt H, Knoke M (1972) Mechanismen der Bakteriostase und Bakterizidie im Magen und oberen Dünndarm. Dtsch Verdauungs Stoffwechselkrkh 32: 209–211

    CAS  Google Scholar 

  2. Bernhardt H, Knoke M (1974) Mikrobielle Besiedlung des Gastrointestinaltraktes und Diarrhoe. Z Inn Med 29: 632–635

    CAS  Google Scholar 

  3. Bernhardt H, Knoke M (1989) Recent studies on the microbial ecology of the upper gastrointestinal tract. Infect 17: 259–263

    Article  CAS  Google Scholar 

  4. Bernhardt H, Schwenke M, Knoke M et al. (1989) Veränderungen der Fäkalflora bei Patienten mit hämatologischen Erkrankungen. Zschr Antim Antineopl Chemoth 7: 49–57

    Google Scholar 

  5. Buts JP, Corthier G, Delmée M (1992) Place of Saccharomyces boulardii in Clostridium difficile-associated diarrhea in children. Interdisciplinary World Congress on Antimicrobial and Anticancer drugs - Intestinal infections: New approaches in control of diarrhea. Symposium, Geneva 31 march 1992 (Abstracts)

    Google Scholar 

  6. Corthier G, Dubos F, Ducluzeau R (1986) Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii. Can J Microbiol 32: 894–896

    Article  PubMed  CAS  Google Scholar 

  7. Corthier G, Muller MC (1988) Emergence in gnotobiotic mice of nontoxinogenic clones of Clostridium difficile from a toxinogenic one. Infect Immun 56: 1500–1504

    PubMed  CAS  Google Scholar 

  8. Czerucka D, Nano JL, Bemasconi P, Rampai P (1991) Réponse aux toxines A et B de Clostridium difficille d’une lignée de cellules épithéliales intestinales de rat: IRD 98. Effét de Saccharomyces boulardii. Gastroenterol Clin Biol 15: 22–27

    PubMed  CAS  Google Scholar 

  9. Elmer GW, McFarland LV (1987) Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters. Antimicrob Agents Chemother 31: 129–131

    PubMed  CAS  Google Scholar 

  10. Elmer GW, Corthier G (1991) Modulation of Clostridium difficile induced mortality as a function of the dose and the viability of the Saccharomyces boulardii uses as a preventative agent in gnotobiotic mice. Can J Microbiol 37: 315–317

    Article  PubMed  CAS  Google Scholar 

  11. Elmer GW, Surawicz CM, McFarland LV, Chinn J (1989) An open trial Vancomycin plus Saccharomyces boulardii for the treatment of relapsing Clostridium difficile diarrhea/colitis. Microecology Therapy 19: 251–256

    Google Scholar 

  12. Gorbach SL, Chang TW, Goldin B (1983) Succesfull treatment of relapsing Clostridium difficile colitis with Lactobacilus GG. Lancet II: 1519

    Google Scholar 

  13. Hagenhoff G, Heidt M, Höchter W (1990) Clostridium difficile und antibiotikaassoziierte Diarrhoen: Prävention und Therapie mit Saccharomyces boulardii. In: Ottenjann R, Müller J, Seifert J (Hrsg) Ökosystem Darm II, Springer, Berlin Heidelberg New York Tokyo S 150–165

    Google Scholar 

  14. Kimmey MB, Eimer GW, Surawicz CM, McFarland LV (1990) Prevention of further rec- curences of Clostridium difficile colitis with Saccharomyces boulardii. Dig Dis Scien 35: 897–901

    Article  CAS  Google Scholar 

  15. Knoke M, Bernhardt H (1986) Mikroökologie des Menschen. Mikroflora bei Gesunden und Kranken. VCH Weinheim

    Google Scholar 

  16. Knoke M, Bernhardt H (1989) Clinical significance of changes of flora in the upper digestive tract. Infection 17: 255–258

    Article  PubMed  CAS  Google Scholar 

  17. Surawicz CM, McFarland LV, Elmer GW, Chinn J (1989) Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. Am J Gastroenterol 84: 1285–1287

    PubMed  CAS  Google Scholar 

  18. Surawicz CM, Elmer GW, Speelmann P et al. (1989) Prevention of antibiotic associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 96: 981–988

    PubMed  CAS  Google Scholar 

  19. Toothaker RD, Elmer GW (1984) Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii. Antimicrob. Agents Chemother 26: 552–556

    PubMed  CAS  Google Scholar 

  20. Tullus K, Aronsson B, Marcus S, Möllby R (1989) Intestinal colonisation with Clostridium difficile in infants up to 18 months. Eur J Clin Microbiol 8: 390–393

    Article  CAS  Google Scholar 

  21. Tvede M, Rask-Madsen J (1989) Bacteriotherapy for chronic relapsing Clostridium difficile diarrhea in six patients. Lancet I: 1156

    Article  Google Scholar 

Download references

Authors
  1. H. Bernhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Innere Medizin II, Medizinische Klinik und Poliklinik, Universitätskliniken des Saarlandes, 66421, Homburg/Saar, Deutschland

    Martin Zeitz

  2. Zentrum der Inneren Medizin, Universitätsklinikum, Theodor-Stem-Kai 7, 60596, Frankfurt, Deutschland

    W. F. Caspary

  3. Nationales Referenzzentrum für Enteritiserreger, Hygienisches Institut, Marckmannstraße 129a, 20539, Hamburg, Deutschland

    Jochen Bockemühl

  4. Medizinsche Klinik, Städtisches Krankenhaus Solingen, Postfach, 42719, Solingen, Deutschland

    Gerd Lux

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Bernhardt, H. (1993). Beeinflussung der Pathogenität von Clostridium difficile durch Saccharomyces boulardii. In: Zeitz, M., Caspary, W.F., Bockemühl, J., Lux, G. (eds) Ökosystem Darm V. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78733-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78733-1_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-57591-7

  • Online ISBN: 978-3-642-78733-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation